Jacob Rosenthal

Mr. Jacob Rosenthal

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2023 in Nature Machine Intelligence
Verified
Journal Article
Open access
PDF file
AKAlexandros Karargyris
Alexandros Karargyris
RURenato Umeton
Renato Umeton
MSMicah J. Sheller
Micah J. Sheller
AAAlejandro Aristizabal
Alejandro Aristizabal
JGJohnu George
Johnu George
PMPeter Mattson
Peter Mattson
Medical artificial intelligence (AI) has tremendous potential to advance healthcare by supporting and contributing to the evidence-based practice of medicine, personalizing patient treatment, reducing costs, and improving both healthcare provider and patient experience. Unlocking this potential requires systematic, quantitative evaluation of the performance of medical AI models on large-scale, heterogeneous data capturing diverse patient populations. Here, to meet this need, we introduce MedPerf, an open platform for benchmarking AI models in the medical domain. MedPerf focuses on enabling federated evaluation of AI models, by securely distributing them to different facilities, such as healthcare organizations. This process of bringing the model to the data empowers each facility to assess and verify the performance of AI models in an efficient and human-supervised process, while prioritizing privacy. We describe the current challenges healthcare and AI communities face, the need for an open platform, the design philosophy of MedPerf, its current implementation status and real-world deployment, our roadmap and, importantly, the use of MedPerf with multiple international institutions within cloud-based technology and on-premises scenarios. Finally, we welcome new contributions by researchers and organizations to further strengthen MedPerf as an open benchmarking platform.

10 September 2021 in Informatics
Verified
Journal Article
Open access
PDF file
ACAlexander Chowdhury
Alexander Chowdhury
JRJacob Rosenthal
Jacob Rosenthal
JWJonathan Waring
Jonathan Waring
RURenato Umeton
Renato Umeton
Machine learning has become an increasingly ubiquitous technology, as big data continues to inform and influence everyday life and decision-making. Currently, in medicine and healthcare, as well as in most other industries, the two most prevalent machine learning paradigms are supervised learning and transfer learning. Both practices rely on large-scale, manually annotated datasets to train increasingly complex models. However, the requirement of data to be manually labeled leaves an excess of unused, unlabeled data available in both public and private data repositories. Self-supervised learning (SSL) is a growing area of machine learning that can take advantage of unlabeled data. Contrary to other machine learning paradigms, SSL algorithms create artificial supervisory signals from unlabeled data and pretrain algorithms on these signals. The aim of this review is two-fold: firstly, we provide a formal definition of SSL, divide SSL algorithms into their four unique subsets, and review the state of the art published in each of those subsets between the years of 2014 and 2020. Second, this work surveys recent SSL algorithms published in healthcare, in order to provide medical experts with a clearer picture of how they can integrate SSL into their research, with the objective of leveraging unlabeled data.

9 February 2024 in Nature Reviews Electrical Engineering
Verified
Journal Article
Closed access
PDF file
CBCagla Deniz Bahadir
Cagla Deniz Bahadir
MOMohamed Omar
Mohamed Omar
JRJacob Rosenthal
Jacob Rosenthal
LMLuigi Marchionni
Luigi Marchionni
BLBenjamin Liechty
Benjamin Liechty
MSMert R. Sabuncu
Mert R. Sabuncu

8 December 2021 in Molecular Cancer Research
Verified
Journal Article
Open access
PDF file
JRJacob Rosenthal
Jacob Rosenthal
RCRyan Carelli
Ryan Carelli
MOMohamed Omar
Mohamed Omar
DBDavid Brundage
David Brundage
EHElla Halbert
Ella Halbert
MLMassimo F. Loda
Massimo F. Loda
Imaging datasets in cancer research are growing exponentially in both quantity and information density. These massive datasets may enable derivation of insights for cancer research and clinical care, but only if researchers are equipped with the tools to leverage advanced computational analysis approaches such as machine learning and artificial intelligence. In this work, we highlight three themes to guide development of such computational tools: scalability, standardization, and ease of use. We then apply these principles to develop PathML, a general-purpose research toolkit for computational pathology. We describe the design of the PathML framework and demonstrate applications in diverse use cases. PathML is publicly available at www.pathml.com.

9 November 2020 in Molecular Cancer Research
Verified
Journal Article
Open access
PDF file
KPKathryn L. Penney
Kathryn L. Penney
STSvitlana Tyekucheva
Svitlana Tyekucheva
JRJacob Rosenthal
Jacob Rosenthal
HFHabiba El Fandy
Habiba El Fandy
RCRyan Carelli
Ryan Carelli
MLMassimo F. Loda
Massimo F. Loda
Gleason score, a measure of prostate tumor differentiation, is the strongest predictor of lethal prostate cancer at the time of diagnosis. Metabolomic profiling of tumor and of patient serum could identify biomarkers of aggressive disease and lead to the development of a less-invasive assay to perform active surveillance monitoring. Metabolomic profiling of prostate tissue and serum samples was performed. Metabolite levels and metabolite sets were compared across Gleason scores. Machine learning algorithms were trained and tuned to predict transformation or differentiation status from metabolite data. A total of 135 metabolites were significantly different (Padjusted < 0.05) in tumor versus normal tissue, and pathway analysis identified one sugar metabolism pathway (Padjusted = 0.03). Machine learning identified profiles that predicted tumor versus normal tissue (AUC of 0.82 ± 0.08). In tumor tissue, 25 metabolites were associated with Gleason score (unadjusted P < 0.05), 4 increased in high grade while the remainder were enriched in low grade. While pyroglutamine and 1,5-anhydroglucitol were correlated (0.73 and 0.72, respectively) between tissue and serum from the same patient, no metabolites were consistently associated with Gleason score in serum. Previously reported as well as novel metabolites with differing abundance were identified across tumor tissue. However, a “metabolite signature” for Gleason score was not obtained. This may be due to study design and analytic challenges that future studies should consider.Implications: Metabolic profiling can distinguish benign and neoplastic tissues. A novel unsupervised machine learning method can be utilized to achieve this distinction.

11 April 2024 in IEEE Access
Verified
Journal Article
Open access
AWAlan Q. Wang
Alan Q. Wang
BKBatuhan K. Karaman
Batuhan K. Karaman
HKHeejong Kim
Heejong Kim
JRJacob Rosenthal
Jacob Rosenthal
RSRachit Saluja
Rachit Saluja
MSMert R. Sabuncu
Mert R. Sabuncu
Interpretability for machine learning models in medical imaging (MLMI) is an important direction of research. However, there is a general sense of murkiness in what interpretability means. Why does the need for interpretability in MLMI arise? What goals does one actually seek to address when interpretability is needed? To answer these questions, we identify a need to formalize the goals and elements of interpretability in MLMI. By reasoning about real-world tasks and goals common in both medical image analysis and its intersection with machine learning, we identify five core elements of interpretability: localization, visual recognizability, physical attribution, model transparency, and actionability. From this, we arrive at a framework for interpretability in MLMI, which serves as a step-by-step guide to approaching interpretability in this context. Overall, this paper formalizes interpretability needs in the context of medical imaging, and our applied perspective clarifies concrete MLMI-specific goals and considerations in order to guide method design and improve real-world usage. Our goal is to provide practical and didactic information for model designers and practitioners, inspire developers of models in the medical imaging field to reason more deeply about what interpretability is achieving, and suggest future directions of interpretability research.